Judge Keenan Rules Against Merck's Expansion Of Lone Pine Process

On August 12, 2013, we reported on the oral arguments, here.

Last Thursday -- while I was busy with other affairs -- Judge Keenan declined to follow Merck's suggestion. He won't get involved in mini-trials, at the fact discovery stage -- for a wider class of Fosamax claims.

And that all makes good sense -- in streamlining, rather than compounding -- the litigation proceedings. Here is his opinion (in the form of a five page low res PDF).